Tag: Brian Levy

Eyevance bags global rights of ophthalmic drug Nexagon from OcuNexus

pharmanewsdaily- October 3, 2018

Eyevance Pharmaceuticals has acquired global licensing rights of ophthalmic drug Nexagon, a 30-base antisense oligomer, from OcuNexus Therapeutics which is being developed for the treatment ... Read More